149 related articles for article (PubMed ID: 27379703)
1. CEBPA mutation in a case of chronic myeloid leukemia presenting in myeloid blast crisis.
Yin Y; Li J; Yan W; Cheng Z; Sun N; Zhang G
Leuk Lymphoma; 2017 Mar; 58(3):708-710. PubMed ID: 27379703
[No Abstract] [Full Text] [Related]
2. A case of near-triploid with t(2;14)(p12;q32) in blast crisis of chronic myeloid leukemia detected by spectral karyotyping (SKY).
de Oliveira FM; Scrideli CA; Tone LG
J Pediatr Hematol Oncol; 2007 Apr; 29(4):274-6. PubMed ID: 17414573
[No Abstract] [Full Text] [Related]
3. Prominent hematogone hyperplasia in BCR-ABL1-positive chronic myelogenous leukemia: mimicking recurrent B-lymphoid blast crisis.
Horna P; Pantazopoulos P; Lancet JE; Moscinski LC; Zhang L
Leuk Lymphoma; 2014 Aug; 55(8):1952-4. PubMed ID: 24304373
[No Abstract] [Full Text] [Related]
4. Tetrasomy of Philadelphia chromosome in myeloblastic crisis of chronic myelogenous leukemia.
Oikawa H; Utsugisawa T; Murai K; Narigasawa Y; Miyairi Y; Shimosegawa K; Suzuki T; Kuriya S
Int J Hematol; 1995 Jun; 61(4):229-30. PubMed ID: 8547613
[No Abstract] [Full Text] [Related]
5. Mutations of the myeloid transcription factor CEBPA are not associated with the blast crisis of chronic myeloid leukaemia.
Pabst T; Stillner E; Neuberg D; Nimer S; Willman CL; List AF; Melo JV; Tenen DG; Mueller BU
Br J Haematol; 2006 May; 133(4):400-2. PubMed ID: 16643447
[TBL] [Abstract][Full Text] [Related]
6. Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations.
Curik N; Laznicka A; Polivkova V; Krizkova J; Pokorna E; Semerak P; Suchankova P; Burda P; Hochhaus A; Machova Polakova K
Leukemia; 2024 Jun; 38(6):1415-1418. PubMed ID: 38615117
[No Abstract] [Full Text] [Related]
7. The beauty and the beast: lymphoma-like morphology of myeloid blast phase in CML.
Asemissen AM; Dierlamm J
Blood; 2017 Sep; 130(10):1274. PubMed ID: 28882836
[No Abstract] [Full Text] [Related]
8. Expression of a multidrug resistance gene in blast crisis of chronic myelogenous leukemia.
Pirker R; Goldstein LJ; Ludwig H; Linkesch W; Lechner C; Gottesman MM; Pastan I
Cancer Commun; 1989; 1(2):141-4. PubMed ID: 2639725
[TBL] [Abstract][Full Text] [Related]
9. Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia.
Colla S; Sammarelli G; Crugnola M; Ascani S; Sabbatini E; Bonomini S; Hojden M; Craviotto L; De Celis I; Morandi F; Caramatti C; Rizzoli V; Giuliani N
Eur J Haematol; 2004 May; 72(5):361-5. PubMed ID: 15059073
[TBL] [Abstract][Full Text] [Related]
10. Sequential mutations causing resistance to both Imatinib Mesylate and Dasatinib in a chronic myeloid leukaemia patient progressing to lymphoid blast crisis.
Stagno F; Stella S; Berretta S; Massimino M; Antolino A; Giustolisi R; Messina A; Di Raimondo F; Vigneri P
Leuk Res; 2008 Apr; 32(4):673-4. PubMed ID: 17889935
[No Abstract] [Full Text] [Related]
11. Lymphoid blast crisis at the onset of chronic myelogenous leukaemia: molecular evidence.
Roman J; Andres P; Jimenez MA; Torres A
Br J Haematol; 1994 Jul; 87(3):624-6. PubMed ID: 7993807
[TBL] [Abstract][Full Text] [Related]
12. Blast crisis of chronic myeloid leukemia with plasmacytoid dendritic cell phenotype associated with a rare fusion transcript, e13a3 BCR-ABL1.
Xu D; Claudiani S; Naresh K; Mucklow S; Neelakantan P; Yebra E; Apperley JF; Khorashad J; Milojkovic D
Leuk Lymphoma; 2019 Dec; 60(12):3090-3091. PubMed ID: 31184233
[No Abstract] [Full Text] [Related]
13. Long duration priapism in blast crisis of chronic myeloid leukemia.
Dogra PN; Kumar P; Goel R; Dash SC
J Assoc Physicians India; 2004 Feb; 52():170. PubMed ID: 15656063
[No Abstract] [Full Text] [Related]
14. Bcr-abl positive blast crisis of chronic myeloid leukemia emerging in a case of metastatic colorectal cancer 3 months after completion of an 8-month course of cetuximab and irinotecan.
Buxhofer-Ausch V; Hinterberger-Fischer M; Hinterberger W
Eur J Haematol; 2006 May; 76(5):447-8. PubMed ID: 16494624
[No Abstract] [Full Text] [Related]
15. Somatic mutations of PHF6 in patients with chronic myeloid leukemia in blast crisis.
Li X; Yao H; Chen Z; Wang Q; Zhao Y; Chen S
Leuk Lymphoma; 2013 Mar; 54(3):671-2. PubMed ID: 22928734
[No Abstract] [Full Text] [Related]
16. Genetic Mutations in a Patient with Chronic Myeloid Leukemia Showing Blast Crisis 10 Years After Presentation.
Sklarz LM; Wittke C; Krohn S; GROßE-Thie C; Junghanss C; Murua Escobar H; Glaeser H
Anticancer Res; 2018 Jul; 38(7):3961-3966. PubMed ID: 29970518
[TBL] [Abstract][Full Text] [Related]
17. Karyotypic findings as an independent prognostic marker in chronic myeloid leukaemia blast crisis.
Nanjangud G; Kadam PR; Saikia T; Bhisey AN; Kumar A; Gopal R; Chopra H; Nair CN; Advani SH
Leuk Res; 1994 May; 18(5):385-92. PubMed ID: 8182930
[TBL] [Abstract][Full Text] [Related]
18. Successful imatinib and arsenic trioxide combination therapy for sudden onset promyelocytic crisis with t(15;17) in chronic myeloid leukemia.
Kashimura M; Ohyashiki K
Leuk Res; 2010 Aug; 34(8):e213-4. PubMed ID: 20299093
[No Abstract] [Full Text] [Related]
19. Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge.
Nand S; Barton K
Leuk Lymphoma; 2007 Feb; 48(2):215-6. PubMed ID: 17325875
[No Abstract] [Full Text] [Related]
20. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]